LOUISBOURG INVESTMENTS INC.

Position in RPRX — Royalty Pharma plc

CIK 2053050 DIEPPE, A3

Position in RPRX

as of Jun 30, 2026 · filed Jul 23, 2026 Compact

Position Value

$28,147

-$25 QoQ

Shares Held

502

-44.5% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#548

of 641 holders

Holding Since

Mar 2025

2 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

LOUISBOURG INVESTMENTS INC. holds $41,332 across 5 Biotechnology names. RPRX ranks #1 (68.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RPRX	Royalty Pharma plc This page	502	$28,147
2	CRSP	CRISPR Therapeutics AG	80	$4,363
3	NTLA	Intellia Therapeutics, Inc.	200	$3,384
4	VRTX	Vertex Pharmaceuticals Inc / Ma	6	$2,980
5	RXRX	Recursion Pharmaceuticals, Inc.	670	$2,458

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$28,147	502	-44.5%	Shares	Sole	2026-07-23
2025-03-31	$28,172	905	—	Shares	Sole	2025-04-17
No filing history on record for this holder in this stock.